Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas

NCT00319735 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

PROCEDURE: Radiation Therapy
PROCEDURE: Surgery
PROCEDURE: Tissue Sample

Sponsor

Nasser Hanna, M.D.

Collaborators

[object Object]
[object Object]